Khosro Shareghi in Woodbridge, Virginia

Additional Medical Specialties Include:
NUCLEAR MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 1971
The Primary Medical Specialty for Khosro Shareghi is listed as: Cardiovascular Disease (cardiology)
Approximate Years of Experience: 53
PAC (PECOS ID)#: 9032174735
NPI #: 1093703076
NPI Created On: 10/12/2005
NPI Last Updated Listed as: 05/22/2013
Primary Taxonomy Code: 174400000X
License Number:
0101042990
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• CareFirst BlueChoice, Inc.
• Group Hospitalization and Medical Services Inc.
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English,German, German.

Services and Procedures include:

1. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
2. Routine ekg using at least 12 leads including interpretation and report
3. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
4. Heart rhythm tracing, analysis, and interpretation of 48-hour ekg
5. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
6. Ultrasound examination and continuous monitoring of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report
7. Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck
8. Ultrasound study of arteries and arterial grafts of both legs
9. Ultrasound scan of blood flow of aorta, vena cava, bypass graphs, or one side of the groin or limited scan
10. New patient office or other outpatient visit, typically 45 minutes
11. Established patient office or other outpatient visit, typically 10 minutes
12. Established patient office or other outpatient visit, typically 15 minutes
13. Established patient office or other outpatient, visit typically 25 minutes
14. Technetium tc-99m sestamibi, diagnostic, per study dose
15. Injection, regadenoson, 0.1 mg